Qiagen NV and Exosome Diagnostics Inc. have expanded their existing strategic partnership to develop a first-in-class, noninvasive molecular diagnostic for use in detecting and monitoring actionable genetic mutations in lung cancer patients.
Research discoveries lead to new tests and procedures for use during early pregnancy.
On January 29, Judith Yost, director of the Division of Laboratory Services at the Centers for Medicare and Medicaid Services, will keynote a webinar on the agency’s newly launched Individualized Quality Control Plan for non-waived laboratories.
Illumina Inc. has entered into a multi-year supply agreement giving LabCorp expanded rights to use Illumina next-generation sequencing and microarray equipment and supplies.
With its acquisition of BioFire Diagnostics, bioMerieux expects to consolidate its position as a major player in infectious disease diagnostics and strengthen its presence in the United States.
The Proyecto Malaria Colombia, a joint health initiative founded to stem the tide of malaria, has won the top 2013 Malaria Champions of the Americas award from the Pan American Health Organization and others.
Molecular Health has joined with GATC Biotech to obtain laboratory information management systems, training, and protocols to support MolecularHealth’s oncology testing and treatment decision support platform.
Biodesix Inc., a fully integrated molecular diagnostic company dedicated to personalizing medicine, has closed a structured debt financing with Capital Royalty Partners LP, providing the company with up to $20 million of capital.
Freeno.me, a project focused on improving early cancer detection, has been named one of five healthcare category winners of the Verizon Powerful Answers award. The project is pursuing the potential of cell-free circulating DNA as a novel biomarker.
GE Healthcare will purchase Thermo Fisher Scientific’s cell culture media and sera, gene modulation, and magnetic beads businesses. Thermo previously agreed to divest the units as part of its acquisition of Life Technologies.